Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Glutathione solution will be infused
If approved, CagriSema would provide patients and healthcare professionals with an additional treatment option supported by results from the REDEFINE clinical program, including robust efficacy, high treatment completion rates, and a tolerability profile consistent with its underlying pharmacology
Randomised double-blind placebo-controlled study of interferon -1a in relapsing/remitting multiple sclerosis
The NDSEG Fellowship is managed by Innovative Technology Solutions of Dayton, Ohio
US$ 22.15
US$ 28.67
US$ 21.54
US$ 20.36
US$ 26.97
